Links to WHO target product profiles (TPPs) and product profile characteristics (PPCs)

For a searchable database of WHO and non-WHO TPP and PPC addressing global health concerns, please visit the TPP Directory here. For a list of WHO TPP and PPC by disease area, please see below.

Antimicrobial resistance

• WHO enteric fever, gonorrhea, neonatal sepsis and urinary tract infections treatment TPPs
• WHO antibacterial resistance diagnostics TPPs

Buruli ulcer

• WHO Buruli ulcer diagnostic TPP

COVID-19

• WHO COVID-19 vaccines TPP
• WHO COVID-19 therapeutics TPP for hospitalized cases
• WHO COVID-19 priority diagnostics TPPs

Enterotoxigenic Escherichia coli

• WHO enterotoxigenic Escherichia coli vaccines PPCs

HIV/AIDS

• WHO HIV point-of-care CD4 diagnostics TPP
• WHO HIV point-of-care infant diagnosis TPP
• WHO HIV prevention monoclonal antibodies PPCs
  

HPV, human papillomavirus

• WHO Human papillomavirus screening tests to detect cervical pre-cancer and cancer TPP
• WHO preferred product characteristics for therapeutic HPV vaccines

Human African trypanosomiasis

• WHO rhodesiense human African trypanosomiasis diagnostics TPP
• WHO gambiense human African trypanosomiasis diagnostics TPP
• WHO gambiense human African trypanosomiasis diagnostics in low prevalence settings TPP
• WHO gambiense human African trypanosomiasis diagnostics for verification of elimination TPP

Influenza

• WHO influenza vaccines PPCs

Leishmaniases

• WHO dermal leishmaniases diagnostic TPP

Leprosy

• WHO leprosy diagnostic in individuals with clinical signs and symptoms TPP
• WHO mycobacterium leprae infection diagnostic among asymptomatic household and familial contacts TPP

Lymphatic filariasis

• WHO lymphatic filariasis diagnostics for surveillance TPP
• WHO lymphatic filariasis diagnostics to support therapeutic decisions TPP

Malaria

• WHO malaria vaccines PPCs

Measles and Rubella

• WHO Measles-rubella microarray patch vaccine TPP
  

Medical devices

• WHO personal protective equipment PPC
  

Middle East respiratory syndrome-related coronavirus (MERS) infection

• WHO MERS coronavirus vaccines TPP
  

Mycetoma

• WHO mycetoma diagnostics TPPs

Onchocerciasis

• WHO onchocerciasis diagnostics to support preventive chemotherapy TPP

Respiratory syncytial virus (RSV) infection

• WHO respiratory syncytial virus vaccines PPCs
• WHO respiratory syncytial virus monoclonal antibodies PPCs
  

Scabies

• WHO scabies diagnostics TPPs

Schistosomiasis

• WHO schistosomiasis diagnostics for monitoring, evaluation and surveillance TPPs

Sexually transmitted infections (STI)

• WHO gonococcal vaccines PPCs
• WHO herpes simplex virus vaccines PPCs
• WHO gonorrhoea treatment TPP

Shigella

• WHO Shigella vaccines PPCs

Snakebite envenoming

• WHO Target product profiles for animal plasma-derived antivenoms: antivenoms for treatment of snakebite envenoming in south Asia
• WHO Target product profiles for animal plasma-derived antivenoms: antivenoms for treatment of snakebite envenoming in sub-Saharan Africa

Soil transmitted helminthiasis

• WHO soil-transmitted helminthiasis diagnostics for monitoring and evaluation TPP

Streptococcus infections

• WHO group A Streptococcus vaccines PPCs
• WHO group B Streptococcus vaccines PPCs

Tuberculosis

• WHO TB vaccines PCCs
• WHO high priority diagnostics TPP
• WHO next-generation TB drug-susceptibility diagnostics TPP
• WHO TB treatment TPP
• WHO TB preventive treatment TPP 

Yaws

• WHO yaws diagnostics TPPs

Zika virus disease

• WHO Zika vaccines TPP 
• WHO Zika diagnostics TPP